MX2010007076A - Nanodispersion. - Google Patents
Nanodispersion.Info
- Publication number
- MX2010007076A MX2010007076A MX2010007076A MX2010007076A MX2010007076A MX 2010007076 A MX2010007076 A MX 2010007076A MX 2010007076 A MX2010007076 A MX 2010007076A MX 2010007076 A MX2010007076 A MX 2010007076A MX 2010007076 A MX2010007076 A MX 2010007076A
- Authority
- MX
- Mexico
- Prior art keywords
- nanodispersion
- nanoparticles
- salts
- water
- sterol
- Prior art date
Links
- 239000002105 nanoparticle Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 229930182558 Sterol Natural products 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 150000003432 sterols Chemical class 0.000 abstract 1
- 235000003702 sterols Nutrition 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Optics & Photonics (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2527MU2007 | 2007-12-24 | ||
| PCT/IN2008/000857 WO2009087678A2 (en) | 2007-12-24 | 2008-12-23 | Nanodispersion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010007076A true MX2010007076A (es) | 2010-09-30 |
Family
ID=40853553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010007076A MX2010007076A (es) | 2007-12-24 | 2008-12-23 | Nanodispersion. |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US8586062B2 (OSRAM) |
| EP (2) | EP2231144B1 (OSRAM) |
| JP (2) | JP5656643B2 (OSRAM) |
| KR (1) | KR101505419B1 (OSRAM) |
| CN (1) | CN101909614B (OSRAM) |
| AP (1) | AP2895A (OSRAM) |
| AU (1) | AU2008346121B2 (OSRAM) |
| BR (1) | BRPI0821514B8 (OSRAM) |
| CA (1) | CA2710525C (OSRAM) |
| CO (1) | CO6290681A2 (OSRAM) |
| DK (1) | DK2231144T3 (OSRAM) |
| EA (1) | EA016434B1 (OSRAM) |
| ES (1) | ES2509490T3 (OSRAM) |
| IL (1) | IL206584A0 (OSRAM) |
| MX (1) | MX2010007076A (OSRAM) |
| NZ (1) | NZ586343A (OSRAM) |
| PL (1) | PL2231144T3 (OSRAM) |
| UA (1) | UA100543C2 (OSRAM) |
| WO (1) | WO2009087678A2 (OSRAM) |
| ZA (1) | ZA201004450B (OSRAM) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8778364B2 (en) * | 2009-06-19 | 2014-07-15 | Sun Pharma Advanced Research Company Ltd. | Nanodispersion of a drug and process for its preparation |
| CN102038635A (zh) * | 2009-10-23 | 2011-05-04 | 天津天士力集团有限公司 | 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法 |
| KR20110056042A (ko) * | 2009-11-20 | 2011-05-26 | 주식회사유한양행 | 종양세포 표적지향을 위한 나노 입자 및 이의 제조방법 |
| JP5824511B2 (ja) | 2010-05-03 | 2015-11-25 | テイコク ファーマ ユーエスエー インコーポレーテッド | 非水タキサンプロエマルジョン配合物ならびにそれを調製および使用する方法 |
| ES2385995B2 (es) * | 2011-01-10 | 2013-05-21 | Universidade De Santiago De Compostela | Nanocápsulas con cubierta polimérica |
| CN102078300B (zh) * | 2011-01-27 | 2012-01-11 | 海南美大制药有限公司 | 托拉塞米脂质体固体制剂 |
| CN102366409B (zh) * | 2011-09-14 | 2013-03-20 | 海南灵康制药有限公司 | 一种尼扎替丁脂质体固体制剂 |
| JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
| BR112015022231B1 (pt) * | 2013-03-14 | 2020-11-24 | Griffith Laboratories International, Inc. | Metodo para tratamento de fungos que causam sigatoka negra em plantaqoes da familia musaceae |
| US20170099833A1 (en) * | 2014-05-30 | 2017-04-13 | Oms Investments, Inc. | Nano-sized water-based dispersion compositions and methods of making thereof |
| KR101692314B1 (ko) * | 2015-03-27 | 2017-01-03 | 주식회사 주빅 | 지용성 약물의 생분해성 고분자 내 용해 시스템: 스마트 폴리머 시스템 |
| US20160346219A1 (en) | 2015-06-01 | 2016-12-01 | Autotelic Llc | Phospholipid-coated therapeutic agent nanoparticles and related methods |
| JP2018516964A (ja) * | 2015-06-09 | 2018-06-28 | サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッドＳｕｎ Ｐｈａｒｍａ Ａｄｖａｎｃｅｄ Ｒｅｓｅａｒｃｈ Ｃｏｍｐａｎｙ Ｌｉｍｉｔｅｄ | 局所進行性または転移性である肝内もしくは肝外胆管または胆嚢のカルシノーマに罹患する患者を治療する方法 |
| CN107551390A (zh) * | 2017-08-21 | 2018-01-09 | 常熟佳禾生物科技有限公司 | 一种用于治疗乳腺小叶增生的中药文胸贴片及其制备方法 |
| JP7383626B2 (ja) * | 2018-03-19 | 2023-11-20 | エピクワイティー ファーマ アーべー | カルシウム欠乏に起因する状態の治療に使用するための組成物 |
| US11423574B2 (en) | 2019-12-17 | 2022-08-23 | Emma Ruccio | Method and apparatus for detecting scoliosis |
| US11877717B2 (en) | 2019-12-17 | 2024-01-23 | Emma Ruccio | Method and apparatus for detecting scoliosis |
| EP3928772B1 (en) * | 2020-06-26 | 2024-06-19 | Algiax Pharmaceuticals GmbH | Nanoparticulate composition |
| JP7745863B2 (ja) * | 2021-04-12 | 2025-09-30 | 国立大学法人広島大学 | 難水溶性物質の可溶化方法および難水溶性物質の可溶化組成物 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6018A (en) * | 1849-01-09 | Improvement in bog-cutters | ||
| US5399363A (en) * | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| US6753006B1 (en) | 1993-02-22 | 2004-06-22 | American Bioscience, Inc. | Paclitaxel-containing formulations |
| US6537579B1 (en) | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
| US6458373B1 (en) * | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| KR19990075621A (ko) * | 1998-03-23 | 1999-10-15 | 임성주 | 경사 평판형 배양조 |
| US6017948A (en) * | 1998-10-30 | 2000-01-25 | Supergen, Inc. | Water-miscible pharmaceutical compositions |
| US6365191B1 (en) * | 1999-02-17 | 2002-04-02 | Dabur Research Foundation | Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof |
| US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| WO2001021174A1 (en) * | 1999-09-23 | 2001-03-29 | Dabur Research Foundation | Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles |
| TWI230616B (en) * | 2000-09-25 | 2005-04-11 | Ind Tech Res Inst | Liposome for incorporating large amounts of hydrophobic substances |
| CA2445763A1 (en) * | 2001-05-01 | 2002-11-07 | Angiotech Pharmaceuticals Inc. | Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions |
| DE10124952A1 (de) * | 2001-05-21 | 2002-12-12 | Bayer Ag | Verfahren zur Herstellung von Nanodispersionen |
| AU2002357012A1 (en) * | 2001-11-27 | 2003-06-10 | Transform Pharmaceuticals, Inc. | Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof |
| US6780324B2 (en) | 2002-03-18 | 2004-08-24 | Labopharm, Inc. | Preparation of sterile stabilized nanodispersions |
| ITMI20022323A1 (it) * | 2002-10-31 | 2004-05-01 | Maria Rosa Gasco | Composizioni farmaceutiche atte al trattamento di malattie oftalmiche. |
| US7670627B2 (en) * | 2002-12-09 | 2010-03-02 | Salvona Ip Llc | pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients |
| US7345093B2 (en) * | 2004-04-27 | 2008-03-18 | Formatech, Inc. | Methods of enhancing solubility of compounds |
| US20050288521A1 (en) * | 2004-06-29 | 2005-12-29 | Phytogen Life Sciences Inc. | Semi-synthetic conversion of paclitaxel to docetaxel |
| MX2007010394A (es) * | 2005-02-24 | 2008-02-19 | Elan Pharma Int Ltd | Formulaciones nanoparticuladas de docetaxel y analogos del mismo. |
| EP2138164A1 (en) | 2005-06-17 | 2009-12-30 | Hospira Australia Pty Ltd | Liquid pharmaceutical formulations of docetaxel |
| CA2626016A1 (en) * | 2005-10-21 | 2007-06-21 | Panacea Biotec Limited | Pharmaceutical composition comprising at least one anticancer drug and at least one polymer |
| KR100917809B1 (ko) * | 2006-05-22 | 2009-09-18 | 에스케이케미칼주식회사 | 우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물 |
| US20100068251A1 (en) * | 2006-10-10 | 2010-03-18 | Jina Pharmaceuticals, Inc. | Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof |
-
2008
- 2008-12-23 AP AP2010005314A patent/AP2895A/xx active
- 2008-12-23 CA CA2710525A patent/CA2710525C/en active Active
- 2008-12-23 WO PCT/IN2008/000857 patent/WO2009087678A2/en not_active Ceased
- 2008-12-23 ES ES08870171.9T patent/ES2509490T3/es active Active
- 2008-12-23 NZ NZ586343A patent/NZ586343A/en not_active IP Right Cessation
- 2008-12-23 EP EP08870171.9A patent/EP2231144B1/en active Active
- 2008-12-23 EP EP14175007.5A patent/EP2853264A1/en not_active Withdrawn
- 2008-12-23 BR BRPI0821514A patent/BRPI0821514B8/pt active IP Right Grant
- 2008-12-23 CN CN200880122577.2A patent/CN101909614B/zh active Active
- 2008-12-23 MX MX2010007076A patent/MX2010007076A/es active IP Right Grant
- 2008-12-23 US US12/810,428 patent/US8586062B2/en not_active Expired - Fee Related
- 2008-12-23 PL PL08870171T patent/PL2231144T3/pl unknown
- 2008-12-23 KR KR1020107014449A patent/KR101505419B1/ko not_active Expired - Fee Related
- 2008-12-23 JP JP2010540226A patent/JP5656643B2/ja active Active
- 2008-12-23 UA UAA201009239A patent/UA100543C2/ru unknown
- 2008-12-23 AU AU2008346121A patent/AU2008346121B2/en active Active
- 2008-12-23 EA EA201070793A patent/EA016434B1/ru not_active IP Right Cessation
- 2008-12-23 DK DK08870171.9T patent/DK2231144T3/da active
-
2010
- 2010-06-23 ZA ZA2010/04450A patent/ZA201004450B/en unknown
- 2010-06-23 IL IL206584A patent/IL206584A0/en unknown
- 2010-07-22 CO CO10089145A patent/CO6290681A2/es not_active Application Discontinuation
-
2013
- 2013-10-03 US US14/045,250 patent/US20140030352A1/en not_active Abandoned
-
2014
- 2014-11-21 JP JP2014237028A patent/JP5937180B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA100543C2 (ru) | Нанодисперсия, включающая наночастицы, которые содержат производное таксана | |
| MX2011013726A (es) | Nanodispersión de un medicamento y proceso para su preparación. | |
| WO2008051245A3 (en) | Nanoparticles for use in immunogenic compositions | |
| CO6331449A2 (es) | Compuesto de polímero ultra absorbente que contiene un polímero ultra absorbente y nanofibrillas celulósicas | |
| BRPI0606280A2 (pt) | composições de bisfosfonato nanoparticulado | |
| WO2008016837A3 (en) | Aqueous compositions containing a hydrophobic material | |
| IL260158B (en) | Pyrazine derivatives, preparations containing them and their uses | |
| PL1957041T3 (pl) | Emulsja olej-w-wodzie i jej zastosowanie dla nadania funkcji | |
| EP1972330A3 (en) | Cosmetic or pharmaceutical compositions comprising modified polysiloxanes with at least one carbamate group | |
| CL2013000094A1 (es) | Procedimiento para la produccion de aglomerados que presentan goma y cera que comprende activacion de la goma, adicion de una masa fundida de goma activada, aglomeración de dichas particulas de goma produciendose en dicho aglomerado humectacion profunda y homogenea; aglomerado; producto mixto de asfalto; y su uso en asfaltos o masas bituminosas. | |
| WO2009101113A3 (en) | Oil-in-water emulsion comprising an amphiphilic polymer | |
| IL244130A0 (en) | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof | |
| GB2485327A (en) | Immunomodulatory compositions comprising a polymer matrix and an oil phase | |
| BR112012031500A8 (pt) | Composições sólidas | |
| WO2008065451A3 (en) | Compositions comprising macromolecular assemblies of lipid and surfactant | |
| WO2007117556A3 (en) | Pharmaceutical compositions and uses thereof | |
| WO2007142888A3 (en) | Concentrated fluoropolymer dispersions stabilized with anionic polyelectrolyte dispersing agents | |
| WO2008067202A3 (en) | Ink for inkjet applications | |
| WO2010125543A3 (en) | Cosmetic composition comprising a surfactant with hlb greater than or equal to 12 and a coated pigment | |
| WO2007017196A3 (de) | Öl-in-wasser emulsionen | |
| BRPI1010369B8 (pt) | composição cosmética em forma de nanoemulsão óleo-em-água e uso de uma composição | |
| WO2012071155A3 (en) | Moisturizing compositions for lip | |
| ATE434944T1 (de) | Farbstoff-emulsion und emulgatorzusammensetzung sowie deren verwendung | |
| BR112012033806A2 (pt) | composição na forma de uma partícula, método para sua preparação e uso da composição | |
| JP2016502979A5 (OSRAM) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |